Quadt, Katharina A.
Smyrnakou, Xanthoula
Frischknecht, Friedrich http://orcid.org/0000-0002-8332-6668
Böse, Guido
Ganter, Markus http://orcid.org/0000-0003-0684-2260
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (13GW0065A, BIO 326-036)
Article History
Received: 25 June 2020
Accepted: 11 October 2020
First Online: 22 October 2020
Compliance with ethical standards
:
: G.B. is founder and CEO of Zendia GmbH with the goal to develop a commercially available rapid diagnostic test, holding the patents WO2018002327A1 and WO2014096462A3 and country registrations. F.F. served as an advisor for Zendia GmbH and co-directs the BMBF <i>KMU-Innovativ</i> grant BIO-370-036 together with G.B. since 2019. K.Q. is currently employed by Zendia GmbH and X.S. and M.G. were temporarily employed by Zendia GmbH. M.G. is listed as co-inventor on the patent WO2018002327A1.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.